COVID-19 Diagnostic Research Report 2025: 5 Year Forecast by Technology, Product, Channel and Country, with Executive and Consultant Guides - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global COVID-19 Diagnostic Market: Forecast by Technology, Product, Channel and Country, with Executive and Consultant Guides" has been added to ResearchAndMarkets.com's offering.

The COVID-19 pandemic's impact lingers, transforming the landscape of respiratory diagnostics. While the immediate crisis has subsided, the virus remains, heralding a fiercely competitive industry eager to capitalize on a lucrative future. This new era sees testing progressively integrated into physicians' offices and homes, sparking interest and innovation. Questions abound: will saliva tests become the norm, or will handheld multiplex testers and home-based testing sticks dominate? How will the Workplace market prioritize safety? And what fate awaits the sprawling laboratory infrastructure established during the pandemic, now facing underutilization? Our comprehensive report delves into these pivotal shifts, equipping you with invaluable insights.

This report is a crucial resource, meticulously examining revenue streams, technological advancements, products, and distribution channels across various countries and regions. With this detailed analysis, you can swiftly gain a nuanced understanding of the evolving market dynamics. Our Market Guides and Situation Analysis empower you to stay ahead, making informed decisions that position you as a leader within your organization.

Moreover, the report provides a forecast spanning the next five years, offering predictive insights that are indispensable in strategic planning. As COVID-19 continues to influence global health and business strategies, this forward-looking outlook becomes essential. Whether you're navigating the complexities of new testing methods or assessing their implications across different sectors, this report offers the clarity and expertise you need.

Seize the chance to transform your approach with cutting-edge data and analysis that illuminate the path forward in respiratory diagnostics. Stay competitive and informed with our report, ensuring you lead with confidence in a market primed for transformation and growth. Discover how to harness these insights to become not just a participant but a frontrunner in the rapidly shifting landscape of COVID-19 diagnostics.

Key Topics Covered:

1 Market Guides
1.1 Strategic Situation Analysis|
1.2 Guidance for Executives
1.3 Guidance for Management Consultants and Investment Advisors

2 Introduction and Market Definition
2.1 What are Pandemics?
2.2 The Role of Zoonosis
2.3 Market Definition
2.3.1 PCR
2.3.2 PCR Multiplex
2.3.3 SEQ
2.3.4 Antigen
2.3.5 Antibodies
2.3.6 Instruments
2.3.7 Reagents and Kits
2.3.8 Extract
2.3.9 Collect
2.3.10 Public
2.3.11 Hospital
2.3.12 Clinic
2.3.13 Workplace
2.3.14 DTC/OTC
2.3.15 Wastewater
2.4 Methodology
2.5 Historical Perspective on Pandemics

3 The Pandemic Overview
3.1 What is a Virus?
3.1.1 Is a Virus Alive?
3.1.2 Viral Structure
3.1.3 The Viral Genome
3.1.4 Viral Mutation
3.2 The Coronavirus
3.2.1 Severe Acute Respiratory Syndrome (SARS)
3.2.2 Middle East Respiratory Syndrome (MERS)
3.2.3 COVID-19. The SARS CoV 2 Virus.
3.2.3.1 Signs and Symptoms
3.2.3.2 Transmission
3.2.3.3 Diagnosis
3.2.3.4 Prevention
3.2.3.5 Management
3.2.3.6 Prognosis
3.2.3.7 A Note on Global Statistics Reporting
3.3 Pandemic Diagnostics
3.3.1 Risk Management - Spark and Spread
3.3.2 Dx Technology - Nucleic Acid-Based
3.3.3 Dx Technology - Immunoassay
3.3.4 Time to Market and Preparedness Issues

4 Industry Structure
4.1 Players in a Dynamic Market
4.1.1 Academic Research Lab
4.1.2 Diagnostic Test Developer
4.1.3 Instrumentation Supplier
4.1.4 Chemical/Reagent Supplier
4.1.5 Pathology Supplier
4.1.6 Independent Clinical Laboratory
4.1.7 Public National/regional Laboratory
4.1.8 Hospital Laboratory
4.1.9 Physicians Office Lab (POLS)
4.1.10 Audit Body
4.1.11 Certification Body

5 Diagnostic Company Profiles
5.1 Advanced Biological Laboratories
5.2 Abbott Laboratories
5.3 Accel Diagnostics
5.4 Accelerate Diagnostics
5.5 Access Bio
5.6 ADT Biotech
5.7 Agilent
5.8 Altona Diagnostics
5.9 Alveo Technologies
5.10 Anatolia Geneworks
5.11 Anitoa
5.12 Applied BioCode
5.13 Applied DNA Sciences
5.14 Aureum Diagnostics
5.15 Aurora Biomed
5.16 Aus Diagnostics
5.17 Autobio Diagnostics
5.18 Autonomous Medical Devices
5.19 Beckman Coulter Diagnostics (Danaher)
5.20 Becton, Dickinson and Company
5.21 BGI Genomics Co. Ltd
5.22 BillionToOne
5.23 Binx Health
5.24 Biocartis
5.25 Biodesix Inc.
5.26 BioFire Diagnostics (bioMerieux)
5.27 BioGX
5.28 Biolidics Ltd
5.29 bioMerieux Diagnostics
5.30 Bioneer Corporation
5.31 Bio-Rad Laboratories, Inc
5.32 Bio-Reference Laboratories
5.33 Boditech Med, Inc
5.34 Bosch Healthcare Solutions GmbH
5.35 Celemics
5.36 Cepheid (Danaher)
5.37 Cerstest Biotec
5.38 Chembio
5.39 Co Diagnostics
5.40 Color Genomics
5.41 CTK Biotech
5.42 Cube Dx
5.43 Cue Health
5.44 Curetis (OpGen)
5.45 Detect
5.46 Diagenode Diagnostics (Hologic)
5.47 Diasorin S.p.A.
5.48 Domus Diagnostics
5.49 Ellume
5.50 Enzo Biochem
5.51 Everywell
5.52 Fluxergy
5.53 Fujirebio
5.54 Fulgent Genetics
5.55 Fusion Genomics.
5.56 Fyr Diagnostics
5.57 Genedrive
5.58 Genetic Signatures
5.59 GenMark Dx (Roche)
5.60 Genomadix
5.61 Gold Standard Diagnostics
5.62 Hologic
5.63 Illumina
5.64 Immunexpress
5.65 Inflammatix
5.66 Innova Medical Group
5.67 J&J Innovative Medicine
5.68 Karius
5.69 Laboratory Corporation of America
5.70 Letsgetchecked
5.71 LightDeck Diagnostics
5.72 LumiraDx
5.73 Mammoth Biosciences
5.74 Mayo Clinic Laboratories
5.75 Meep
5.76 Meridian Bioscience
5.77 Mesa Laboratories, Inc.
5.78 Molbio Diagnostics
5.79 NanoDx
5.80 Nanomix
5.81 Novacyt
5.82 Nuclein
5.83 OnsiteGene
5.84 OraSure Technologies
5.85 Oxford Nanopore Technologies
5.86 Prenetics
5.87 Primerdesign (Novacyt)
5.88 Prominex
5.89 Proof Diagnostics
5.90 Qiagen
5.91 QuantuMDx
5.92 Quest Diagnostics
5.93 QuidelOrtho
5.94 Randox Toxicology
5.95 R-Biopharm AG
5.96 Revvity
5.97 Roche Diagnostics
5.98 Salignostics
5.99 Scope Fluidics
5.100 SD Biosensor
5.101 Seegene
5.102 Sekisui Diagnostics
5.103 Sherlock Biosciences
5.104 Siemens Healthineers
5.105 Singular Genomics
5.106 Sona Nanotech
5.107 SpeeDx
5.108 Standard BioTools
5.109 Streamline Scientific
5.110 Talis Biomedical
5.111 Thermo Fisher Scientific
5.112 Ultima Genomics
5.113 Uniogen
5.114 Vela Diagnostics
5.115 Veredus Laboratories
5.116 Vircell
5.117 Visby Medical
5.118 Wantai Biopharm
5.119 YD Diagnostics
5.120 Zhejiang Orient Gene Biotech

6 COVID-19 Diagnostics Recent Developments
6.1 Recent Developments - Importance and How to Use This Section
6.1.1 Importance of These Developments
6.1.2 How to Use This Section
6.2 Impact of Long COVID Revealed
6.3 QuidelOrtho Receives Clearance for Home COVID-19 Test
6.4 SEKISUI Dx Receives EAU for the OSOM Flu SARS-CoV-2 Combo Test
6.5 Johns Hopkins Shows COVID-19 Tests Done at Home Are Reliable
6.6 Walgreens Offers COVID-19 and Flu Testing
6.7 Home Test to Treat program extends nationwide
6.8 New test for long COVID-19 Possible
6.9 Labcorp Gets Approval for Sequencing-Based COVID Test
6.10 Post-Pandemic, Patients Savvy About ID Diagnostics
6.11 Discover Labs Obtains EUA for RT-PCR COVID Test
6.12 Sensible Dx to Launch 10-Minute POC PCR System
6.13 Aptitude Medical Systems Aiming for At-Home Market
6.14 Qorvo To Emerge as More Than a COVID Company
6.15 End of COVID-19 Emergency Lowers Diagnostics Revenue
6.16 FDA Issues EUA for GenBody At-Home COVID Test
6.17 CTK Biotech Gets EAU for At-Home COVID Antigen Test
6.18 FDA Grants EAU for Premier Medical At-Home COVID Assay
6.19 QuidelOrtho Seeks Home Testing Contract
6.20 Aptitude Medical Gets EUA for Over-the-Counter COVID Saliva MDx
6.21 Siemens Healthineers Gains CE Marks for Seasonal Viral Assays
6.22 NanoDx Prepares for POC Platform Commercialization With TBI, COVID Tests
6.23 North American Dx Recalls Covid Rapid Antigen Tests
6.24 Domus Dx to Launch OC Diagnostics Test System
6.25 Becton Dickinson, ReturnSafe Collaborate on COVID-19 Testing
6.26 Mammoth Biosciences High-Throughput CRISPR-Based COVID Test Gets FDA EUA 301
6.27 At-Home COVID Test Coverage
6.28 LuminUltra Wins 500-Site CDC Wastewater Testing Contract
6.29 Sense Biodetection to Debut Instrument-Free Point-of-Care MDx
6.30 Tests Called Back

7 The Global Market for COVID-19 Diagnostics
7.1 Global Market Overview by Country
7.2 Global Market by Technology - Overview
7.3 Global Market by Product - Overview
7.4 Global Market by Channel - Overview

8 Global COVID-19 Diagnostic Markets - By Technology
8.1 PCR
8.2 PCR Multiplex
8.3 Sequencing
8.4 Antibody
8.5 Antigen

9 Global COVID-19 Diagnostic Markets - By Product
9.1 Instruments
9.2 Reagents & Kits
9.3 Extraction
9.4 Collection

10 Global COVID-19 Diagnostic Markets - By Channel
10.1 Public
10.2 Hospital
10.3 Clinic
10.4 Workplace
10.5 DTC/OTC
10.6 Wastewater

11 Appendix
11.1 U.S., Europe, Asia Approved COVID-19 Assays

For more information about this report visit https://www.researchandmarkets.com/r/doly78

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.